SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Jun-24 4:03 PM View: | SCYNEXIS, Inc. (SCYX) | 20-Jun-24 | Grant | 23,000 | -- | -- | 92% 25.0K to 48.0K | |
11-Oct-23 9:52 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Grant | 240,000 | -- | -- | 25% 976.61K to 1.22M | |
11-Oct-23 9:52 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Disposition (change in control) | 1,176,720 | -- | -- | (97%) 1.22M to 39.89K | |
11-Oct-23 9:52 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Disposition (change in control) | 39,892 | -- | -- | (100%) 39.89K to 0 | |
14-Sep-23 4:13 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 13-Sep-23 | Sale | 17,830 | $1.33 | $23,637.20 | (2%) 967.85K to 950.02K | |
14-Sep-23 4:13 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 12-Sep-23 | Grant | 64,747 | -- | -- | 7% 903.1K to 967.85K | |
23-Jun-23 4:15 PM View: | SCYNEXIS, Inc. (SCYX) | 15-Jun-23 | Grant | 10,000 | -- | -- | 67% 15.0K to 25.0K | |
09-Feb-23 5:10 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 08-Feb-23 | Payment of Exercise | 12,547 | $0.60 | $7,484.29 | (1%) 915.65K to 903.1K | |
09-Feb-23 5:10 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 07-Feb-23 | Grant | 45,406 | -- | -- | 5% 870.24K to 915.65K | |
02-Feb-23 8:13 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 01-Feb-23 | Payment of Exercise | 11,726 | $0.60 | $6,979.32 | (1%) 881.97K to 870.24K | |
02-Feb-23 8:13 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 31-Jan-23 | Grant | 42,437 | -- | -- | 5% 839.53K to 881.97K | |
25-Jan-23 5:25 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 24-Jan-23 | Grant | 250,000 | -- | -- | 42% 589.53K to 839.53K | |
25-Jan-23 5:25 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 23-Jan-23 | Sale | 35,453 | $0.60 | $21,193.80 | (6%) 624.99K to 589.53K | |
20-Jul-22 4:05 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 19-Jul-22 | Sale | 11,899 | $1.10 | $13,088.90 | (2%) 636.88K to 624.99K | |
20-Jul-22 4:05 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 18-Jul-22 | Grant | 43,164 | -- | -- | 7% 593.72K to 636.88K | |
22-Jun-22 4:01 PM View: | SCYNEXIS, Inc. (SCYX) | 17-Jun-22 | Grant | 10,000 | -- | -- | 200% 5.0K to 15.0K | |
28-Jan-22 4:28 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 26-Jan-22 | Grant | 120,000 | -- | -- | 25% 473.72K to 593.72K | |
25-Jan-21 4:21 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 21-Jan-21 | Grant | 107,911 | -- | -- | 29% 365.81K to 473.72K | |
23-Dec-20 9:02 AM View: | SCYNEXIS, Inc. (SCYX) | 21-Dec-20 | Market Purchase | 5,000 | $6.25 | $31,250.00 | 100% 0 to 5.0K | 6% |
07-Aug-18 4:32 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 06-Aug-18 | Market Purchase | 15,000 | $5.96 | $89,422.50 | 4% 350.81K to 365.81K | (41%) |
16-May-17 8:50 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 15-May-17 | Market Purchase | 1,500 | $19.57 | $29,355.00 | < 1% 349.31K to 350.81K | (82%) |
16-May-17 8:50 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 12-May-17 | Market Purchase | 3,500 | $19.76 | $69,160.00 | 1% 345.81K to 349.31K | (82%) |
10-Aug-15 3:05 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Aug-15 | Conversion | 39,892 | -- | -- | (150%) (-26.59K) to 13.3K | |
25-Feb-14 10:31 AM View: | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 1,270,000 | $6.80 | $8,636,000.00 | (100%) 1.27M to 0 | |
22-Jan-13 10:05 AM View: | Nupathe Inc. (PATH) | 17-Jan-13 | Grant | 317,580 | -- | -- | 33% 952.42K to 1.27M | |
09-Jan-13 6:29 PM View: | Nupathe Inc. (PATH) | 07-Jan-13 | Grant | 369,095 | -- | -- | 63% 583.33K to 952.42K | |
03-Jan-13 3:37 PM View: | Nupathe Inc. (PATH) | 31-Dec-12 | Grant | 583,325 | -- | -- | (125%) (-466.66K) to 116.67K | |
08-Dec-11 2:56 PM View: | Adolor Corp. (ADLR) | 07-Dec-11 | Option Exercise | 150,000 | $1.94 | $290,400.00 | 1435% 10.45K to 160.45K | |
08-Dec-11 2:56 PM View: | Adolor Corp. (ADLR) | 07-Dec-11 | Disposition (change in control) | 160,450 | -- | -- | (100%) 160.45K to 0 | |
11-Oct-11 9:33 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Oct-11 | Option Exercise | 5,275 | $7.81 | $41,197.80 | 4% 147.14K to 152.41K | |
11-Oct-11 9:33 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Oct-11 | Market Option Sale (Planned) | 5,275 | $14.23 | $75,045.80 | (3%) 152.41K to 147.14K | (142%) |
12-Jul-11 7:49 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 08-Jul-11 | Option Exercise | 5,275 | $7.81 | $41,197.80 | 4% 147.14K to 152.41K | |
12-Jul-11 7:49 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 08-Jul-11 | Market Option Sale (Planned) | 5,275 | $20.30 | $107,101.00 | (3%) 152.41K to 147.14K | (70%) |
09-Mar-11 7:15 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 08-Mar-11 | Option Exercise | 10,555 | $7.81 | $82,434.50 | 7% 149.56K to 160.11K | |
09-Mar-11 7:15 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 08-Mar-11 | Market Option Sale (Planned) | 10,555 | $23.02 | $242,993.00 | (7%) 160.11K to 149.56K | (50%) |
12-Jan-11 9:33 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 10-Jan-11 | Option Exercise | 10,555 | $7.81 | $82,434.50 | 7% 149.56K to 160.11K | |
12-Jan-11 9:33 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 10-Jan-11 | Market Option Sale (Planned) | 10,555 | $23.22 | $245,050.00 | (7%) 160.11K to 149.56K | (48%) |
02-Aug-10 7:27 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 29-Jul-10 | Gift | 53,537 | -- | -- | 36% 149.56K to 203.09K | |
02-Aug-10 7:27 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 29-Jul-10 | Gift | 53,537 | -- | -- | (26%) 203.09K to 149.56K | |
20-Jul-10 6:53 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 17-Jul-10 | Payment of Exercise | 32,080 | $22.22 | $712,818.00 | (18%) 181.63K to 149.56K | (56%) |
19-May-10 3:20 PM View: | Adolor Corp. (ADLR) | 18-May-10 | Grant | 4,437 | -- | -- | 74% 6.01K to 10.45K | |
14-Apr-10 7:05 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 12-Apr-10 | Option Exercise | 30,000 | $7.81 | $234,300.00 | 17% 181.63K to 211.63K | |
14-Apr-10 7:05 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 12-Apr-10 | Market Option Sale (Planned) | 30,000 | $33.07 | $992,115.00 | (14%) 211.63K to 181.63K | (5%) |
16-Mar-10 6:09 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 12-Mar-10 | Payment of Exercise | 2,419 | $30.20 | $73,053.80 | (1%) 184.05K to 181.63K | |
02-Mar-10 7:28 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 28-Feb-10 | Grant | 24,108 | -- | -- | 15% 159.95K to 184.05K | |
14-Sep-09 4:03 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 11-Sep-09 | Gift | 30,317 | -- | -- | 19% 159.95K to 190.26K | |
14-Sep-09 4:03 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 11-Sep-09 | Gift | 58,339 | -- | -- | 31% 190.26K to 248.6K | |
14-Sep-09 4:03 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 11-Sep-09 | Gift | 30,317 | -- | -- | (12%) 248.6K to 218.28K | |
14-Sep-09 4:03 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 11-Sep-09 | Gift | 58,339 | -- | -- | (27%) 218.28K to 159.95K | |
21-Jul-09 6:07 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 17-Jul-09 | Payment of Exercise | 16,032 | $30.00 | $480,960.00 | (13%) 124.05K to 108.02K | (19%) |